BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6201645)

  • 21. Kinin activation and protease inhibitors in acute pancreatitis in man.
    Lasson A; Ohlsson K
    Adv Exp Med Biol; 1986; 198 Pt B():423-32. PubMed ID: 2433917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma kallikrein activity and prekallikrein levels during endotoxin shock in dogs.
    Aasen AO; Frolich W; Saugstad OD; Amundsen E
    Eur Surg Res; 1978; 10(1):50-62. PubMed ID: 344043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Aspects of hemostasis and the immunology of burns].
    Hainaut J
    Biomed Pharmacother; 1987; 41(2):84-8. PubMed ID: 2440499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Status of the inhibitor system of proteolysis enzymes in acute cholecystitis and pancreatitis].
    Protsenko AV; Starosek VN; Protsenko VA
    Sov Med; 1981; (7):16-20. PubMed ID: 6170117
    [No Abstract]   [Full Text] [Related]  

  • 25. Binding of a monoclonal anti-human plasma prekallikrein antibody to the complexes of kallikrein with C1-inhibitor and alpha 2-macroglobulin analyzed by immunoblot and "sandwich" assays.
    Veloso D; Tseng SY; Craig AR; Colman RW
    Adv Exp Med Biol; 1989; 247A():499-505. PubMed ID: 2481391
    [No Abstract]   [Full Text] [Related]  

  • 26. A study of the plasma kinin-generating system in children with the minimal lesion, idiopathic nephrotic syndrome.
    Kallen RJ; Lee SK
    Pediatr Res; 1975 Sep; 9(9):705-9. PubMed ID: 53808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of food loading on the activity of the kallikrein-kinin system of the blood in an experiment].
    Tsagikian TA; Frolova IA
    Vopr Pitan; 1988; (1):35-9. PubMed ID: 2452520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Study of the prekallikrein-kallikrein system of the blood plasma in children with viral hepatitis].
    Veremeenko GI; Moshchich PS; Vasilenko GI; Meged' NF
    Pediatr Akus Ginekol; 1977; (1):28-30. PubMed ID: 882294
    [No Abstract]   [Full Text] [Related]  

  • 29. [Significance of kallikrein, angiotensin-converting enzyme, and proteolysis inhibitors in vascular complications in diabetes mellitus type 1 in children].
    Sukhanova GA; Kondrat'eva EI; Spirina LV
    Klin Lab Diagn; 2004 May; (5):38-40. PubMed ID: 15230115
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Characterization of shock sensitivity in experimental hemorrhagic shock (5,3 and 8,0 kPa) by determining kallikrein, kallikreinogen, non-specific proteases and inhibitor capacity of blood plasma].
    Kühne H; Lehmann B; Taucher M; Scheuch DW
    Z Med Lab Diagn; 1983; 24(3):123-8. PubMed ID: 6351457
    [No Abstract]   [Full Text] [Related]  

  • 31. [Protease and protease inhibitor activity of blood serum].
    Rudenko VG; Levitskiĭ AP
    Vrach Delo; 1986 Jun; (6):33-6. PubMed ID: 2428169
    [No Abstract]   [Full Text] [Related]  

  • 32. [Immune complexes and various indicators of the kallikrein-kinin system in psoriasis].
    Voloshin RN; Mezhova LI; Kozlova LS
    Vestn Dermatol Venerol; 1981 Mar; (3):25-7. PubMed ID: 6973253
    [No Abstract]   [Full Text] [Related]  

  • 33. [Status of the kallikrein-kinin system of the blood in young and middle-aged patients with ischemic heart disease].
    Tsagikian TA; Frolova IA; Paramonova EG
    Vopr Med Khim; 1984; 30(1):104-8. PubMed ID: 6200999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Study of prekallikrein-kallikrein system of blood plasma in acute pancreatitis].
    Veremeenko KN; Verevka VS; Meged' NF
    Klin Khir (1962); 1976 Sep; 00(9):5-9. PubMed ID: 978911
    [No Abstract]   [Full Text] [Related]  

  • 35. [The role of biologically active substances in the pathogenesis of dysfunctional uterine hemorrhage in the climacteric period].
    Strizhova NV; Diugeev AN; Popov AD
    Akush Ginekol (Mosk); 1991 Jul; (7):63-5. PubMed ID: 1719838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of sepsis in the surgical patient evaluated by means of chromogenic peptide substrate assays.
    Smith-Erichsen N; Aasen AO; Amundsen E
    Acta Chir Scand Suppl; 1982; 509():33-8. PubMed ID: 6187146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Determination of plasma kallikrein and prekallikrein in patients with epidemic hemorrhagic fever and its clinical significance].
    Tong MQ
    Zhonghua Yi Xue Za Zhi; 1987 May; 67(5):256-7. PubMed ID: 2888524
    [No Abstract]   [Full Text] [Related]  

  • 38. Western blot analyses of prekallikrein and its activation products in human plasma.
    Veloso D; Colman RW
    Thromb Haemost; 1991 Apr; 65(4):382-8. PubMed ID: 1711719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Main proteolytic inhibitors in ocular herpes].
    Chesnokova NB; Kasavina BS; Maĭchuk IuF; Kazachenko MA; Shchipanova AI
    Vopr Med Khim; 1981; 27(5):663-5. PubMed ID: 6171934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Determination of components of blood kallikrein-kinin system during therapy of patients with peptic ulcer].
    Orlov VA; Surovikina MS; Rodionov AV; Fomina EE; Bogdanovich AI
    Klin Med (Mosk); 1989 Sep; 67(9):70-4. PubMed ID: 2586047
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.